A host of pharma industry experts discuss the increasing use of digital technology in decentralized clinical trials

In this video roundtable, Lokavant CEO Rohit Nambisan, Medable CSO Pam Tenaerts, and Curavit Clinical Research CEO Joel Morse discuss the increasing use of digital technology in decentralized clinical trials. In the wake of the COVID-19 pandemic, clinical researchers were driven to sourcing and enrolling trial participants in new ways, which has enabled more diverse demographics to participate. With the expanded representation of cultural minorities, our experts expect more accuracy in the growing data sets, but what other advantages are there to decentralized clinical trials? What are the obstacles and the challenges being faced in this relatively young practice? And what does the future look like? Watch our video roundtable now to find out what our experts think.